NASDAQ Companies

Therapy Demonstrated Safety, Stabilization/Shrinkage of Treated Tumors Expanded Development for Monotherapy and Combination Therapy Anticipated ATLANTA, GA, Jan. 04, 2024 […]

TOKYO, Jan. 04, 2024 (GLOBE NEWSWIRE) — SYLA Technologies Co., Ltd. (NASDAQ: SYT) (“SYLA” or “the Company”), operator of the […]

CASTLE ROCK, Colo., Jan. 04, 2024 (GLOBE NEWSWIRE) — Riot Platforms, Inc. (NASDAQ: RIOT) (“Riot” or “the Company”), an industry […]

Edible Garden’s Pulp line of sustainable gourmet USDA Organic fermented sauces BELVIDERE, NJ, Jan. 04, 2024 (GLOBE NEWSWIRE) — Edible […]

SALT LAKE CITY, Jan. 04, 2024 (GLOBE NEWSWIRE) — SINTX Technologies, Inc. (www.sintx.com) (NASDAQ: SINT; “SINTX” or the “Company”), a […]

CELEBRATION, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) — Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra or the Company), a rare disease therapeutics […]

Final validation report expected in first quarter 2024 ENGLEWOOD CLIFFS, NJ, Jan. 04, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: […]

MIAMI, Jan. 04, 2024 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company […]

The Company’s 84-qubit Ankaa™-2 system is now publicly available to all of its customers via Rigetti Quantum Cloud Services (QCS™). […]

SEATTLE, Jan. 04, 2024 (GLOBE NEWSWIRE) — Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of […]